Induction of host matrix metalloproteinases by Borrelia burgdorferi differs in human and murine lyme arthritis.
Level 5 - mechanism / opinion, no new human data
Bench and animal research with human tissue analysis (mechanism-based reasoning)
PubMed 15618147 · doi:10.1128/IAI.73.1.126-134.2005
What was done
The authors evaluated matrix metalloproteinase (MMP) expression patterns following Borrelia burgdorferi infection across primary human chondrocytes, synovial fluid samples from patients with Lyme arthritis (stratified by high versus low spirochete burden), and cartilage tissue from Lyme arthritis-susceptible (C3H/HeN) and -resistant (BALB/c and C57BL/6) mice. Measurements were performed using gene arrays, real-time PCR, enzyme-linked immunosorbent assays (ELISA), and immunohistochemistry.
What was found
The abstract reports qualitative directions of effect without numerical values or exact statistics. B. burgdorferi infection significantly induced transcription of MMP-1, -3, -13, and -19 in primary human chondrocytes. MMP-10 and tissue inhibitor of metalloprotease 1 (TIMP-1) transcription increased, but protein levels were only minimally increased. Synovial fluid MMP levels in human patients matched the in vitro findings. In contrast, susceptible C3H/HeN mice showed induction of only MMP-3 and MMP-19 (with MMP-3 localized to chondrocytes near the articular surface) and lacked collagenase induction (MMP-1, MMP-13). Resistant mouse strains showed significantly lower MMP levels than susceptible mice.
Why it matters
This study demonstrates species-specific divergence in Lyme arthritis pathogenesis: human tissues upregulate destructive collagenases (MMP-1 and MMP-13) in response to B. burgdorferi, whereas murine models do not. These findings identify limitations in mouse models for studying human Lyme arthritis joint destruction.
Limits
The abstract provides no sample sizes for human synovial fluid samples, cell culture replicates, or animal groups. No quantitative values, fold-changes, or exact p-values are reported. As a mechanistic study, it does not evaluate clinical interventions targeting MMP pathways in patients.
Cited by
- supports Matrix metalloproteinases (MMPs) are elevated when Lyme disease affects the joints.